Key Highlights
- Enovix shares rose 10.8% to USD 2.00 in pre-market dealings on Friday, November 13, 2026, the day after third-quarter results and a fiscal 2027 Revenue outlook were published.
- Third-quarter revenue hit USD 11.0 million, which is 38% above the USD 8.0 million of a year earlier and 22% above the second quarter, while the GAAP net loss came to USD 41.9 million, or USD 0.19 per share.
- Fiscal 2027 revenue guidance sits at USD 65.0 million to USD 85.0 million, measured against an estimated USD 36.7 million to USD 37.7 million for 2026, and fourth-quarter revenue is pencilled in at USD 9.0 million to USD 10.0 million.
- On October 4, 2026, cash, securities and restricted cash added up to USD 512.2 million, or USD 2.35 a share, and the company retired USD 128 million of 2030 convertible notes for roughly USD 81 million.
Third-Quarter Revenue Clears the Guided Range
The company put out its third-quarter 2026 numbers on November 12, 2026. Sales of USD 11.0 million cleared the USD 9.0 million to USD 10.0 million band management had flagged, and that total agrees with a preliminary update released on October 12, 2026. Gross Margin on a GAAP basis was 30.1%, while the non-GAAP measure set a record at 34.5%. The non-GAAP loss, USD 31.9 million or USD 0.15 a share, came in a little wider than the USD 0.14 forecast in the preliminary update. For the fourth quarter, revenue is seen 12% to 20% lower than a year earlier, with a non-GAAP operating loss in the USD 28.0 million to USD 31.0 million range.
Drone Orders, a Warrant Distribution and Note Retirement
A first purchase order for 100,000 batteries came from a multinational dual-use drone provider, and a first production order for its MX1-B01 drone cell was also received, with deliveries slated to begin in early 2027. Enovix (NASDAQ:ENVX) intends to put USD 19 million into doubling drone battery output in South Korea. Shareholders on the November 13, 2026 Record Date will receive one warrant for each four shares, struck at USD 3.00, with distribution around November 18 and expiry on April 28, 2028. Buying back USD 128 million of notes at roughly USD 81 million creates an approximate USD 47 million gain, which the company said will appear solely in GAAP reporting.
A Steep 2027 Ramp Against a Cash Cushion
Enovix (NASDAQ:ENVX) faces a steep 2027 target. Against the 2026 estimate, the USD 65.0 million to USD 85.0 million outlook works out to roughly 1.7 to 2.3 times higher (calculated). Cost actions removed 220 roles, a move expected to save around USD 8.5 million annually, and the smartphone cell program is ending field tests for pre-AI-2 cells that missed an energy-density goal, with silicon-anode efforts redirected to smart eyewear. Using the 218,348,968 shares outstanding on October 4, 2026, a USD 2.00 share price equals a Market Value near USD 437 million (calculated), beneath reported cash. Whether the note retirement is reflected in the October 4 cash figure is unconfirmed, and pre-market Volume may be light.
Where Things Stand
The likeliest driver is the November 12 report, as no other pre-market catalyst surfaced. Enovix (NASDAQ:ENVX) topped its own revenue guidance, set a fiscal 2027 range well above 2026 and linked it to drone and defence orders, while the restructuring and note retirement trimmed costs and debt. Offsetting that, the company is still loss-making, fourth-quarter revenue is guided lower year over year, and the pre-market quote may reverse. Watch the November 18 warrant distribution, deliveries that begin in early 2027 and the Korea capacity expected to come online in the second quarter of 2027.






Please wait processing your request...